1. Home
  2. INVZ vs MNPR Comparison

INVZ vs MNPR Comparison

Compare INVZ & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • MNPR
  • Stock Information
  • Founded
  • INVZ 2016
  • MNPR 2014
  • Country
  • INVZ Israel
  • MNPR United States
  • Employees
  • INVZ N/A
  • MNPR N/A
  • Industry
  • INVZ Auto Parts:O.E.M.
  • MNPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVZ Consumer Discretionary
  • MNPR Health Care
  • Exchange
  • INVZ Nasdaq
  • MNPR Nasdaq
  • Market Cap
  • INVZ 114.2M
  • MNPR 113.5M
  • IPO Year
  • INVZ N/A
  • MNPR 2019
  • Fundamental
  • Price
  • INVZ $1.15
  • MNPR $25.82
  • Analyst Decision
  • INVZ Buy
  • MNPR Strong Buy
  • Analyst Count
  • INVZ 6
  • MNPR 3
  • Target Price
  • INVZ $3.81
  • MNPR $27.33
  • AVG Volume (30 Days)
  • INVZ 6.1M
  • MNPR 101.2K
  • Earning Date
  • INVZ 11-13-2024
  • MNPR 11-08-2024
  • Dividend Yield
  • INVZ N/A
  • MNPR N/A
  • EPS Growth
  • INVZ N/A
  • MNPR N/A
  • EPS
  • INVZ N/A
  • MNPR N/A
  • Revenue
  • INVZ $33,158,000.00
  • MNPR N/A
  • Revenue This Year
  • INVZ $18.38
  • MNPR N/A
  • Revenue Next Year
  • INVZ $244.43
  • MNPR N/A
  • P/E Ratio
  • INVZ N/A
  • MNPR N/A
  • Revenue Growth
  • INVZ 339.99
  • MNPR N/A
  • 52 Week Low
  • INVZ $0.45
  • MNPR $1.55
  • 52 Week High
  • INVZ $2.82
  • MNPR $38.50
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 69.41
  • MNPR 57.88
  • Support Level
  • INVZ $1.05
  • MNPR $22.61
  • Resistance Level
  • INVZ $1.37
  • MNPR $32.20
  • Average True Range (ATR)
  • INVZ 0.14
  • MNPR 3.36
  • MACD
  • INVZ 0.05
  • MNPR -0.03
  • Stochastic Oscillator
  • INVZ 70.98
  • MNPR 47.01

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: